Skip to main content
. 2009 Aug 28;11(4):208. doi: 10.1186/bcr2237

Table 2.

Novel cytotoxic agents under investigation or approved for metastatic breast cancer

Agent Drug class Stage of development in breast cancer
Nanoparticle albumin-bound (nab-) paclitaxel Taxane Approved
Larotaxel Taxane III
Ixabepilone Epothilone Approved
Patupilone Epothilone II
ZK-EPO Epothilone II
BMS-310705 Epothilone I
KOS-862 Epothilone Discontinued
Vinflunine Vinca alkaloid II
Eribulin Mitotic inhibitor III
Trabectedin Nucleotide excision repair inhibitor, cell cycle inhibitor III